{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:38:31Z","timestamp":1787841511228,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12282-026-01883-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:14:34Z","timestamp":1781745274000},"page":"1102-1117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying breast cancer subtypes and exploring spatial expression patterns of the key subtype-specific gene based on pathological images, single-cell sequencing, and spatial transcriptomic data"],"prefix":"10.1007","volume":"33","author":[{"given":"Ling-Gen","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Feng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Zhu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Kun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"1883_CR1","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1111\/cas.16208","volume":"115","author":"Q Yan","year":"2024","unstructured":"Yan Q, Deng Y, Zhang Q. A comprehensive overview of metaplastic breast cancer: Features and treatments. Cancer Sci. 2024;115:2506\u201314.","journal-title":"Cancer Sci"},{"key":"1883_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","volume":"186","author":"E Nolan","year":"2023","unstructured":"Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186:1708\u201328.","journal-title":"Cell"},{"key":"1883_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13058-022-01574-4","volume":"24","author":"EA Kolyvas","year":"2022","unstructured":"Kolyvas EA, Caldas C, Kelly K, Ahmad SS. Androgen receptor function and targeted therapeutics across breast cancer subtypes. Breast Cancer Res. 2022;24:79.","journal-title":"Breast Cancer Res"},{"key":"1883_CR4","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","volume":"5","author":"YJ Qi","year":"2024","unstructured":"Qi YJ, Su GH, You C, Zhang X, Xiao Y, Jiang YZ, et al. Radiomics in breast cancer: Current advances and future directions. Cell Rep Med. 2024;5:101719.","journal-title":"Cell Rep Med"},{"key":"1883_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23:261.","journal-title":"Mol Cancer"},{"key":"1883_CR6","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00109.2021","volume":"321","author":"KM Turner","year":"2021","unstructured":"Turner KM, Yeo SK, Holm TM, Shaughnessy E, Guan JL. Heterogeneity within molecular subtypes of breast cancer. Am J Physiol Cell Physiol. 2021;321:C343\u201354.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1883_CR7","doi-asserted-by":"publisher","first-page":"10865","DOI":"10.1002\/cam4.5792","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Wu S, Ma F, Ji JS, Lu L, Ran X, et al. Disparities in stage at diagnosis among breast cancer molecular subtypes in China. Cancer Med. 2023;12:10865\u201376.","journal-title":"Cancer Med"},{"key":"1883_CR8","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.7150\/thno.96163","volume":"14","author":"ZJ Gao","year":"2024","unstructured":"Gao ZJ, Fang H, Sun S, Liu SQ, Fang Z, Liu Z, et al. Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype. Theranostics. 2024;14:3104\u201326.","journal-title":"Theranostics"},{"key":"1883_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-024-02017-8","volume":"23","author":"W Qin","year":"2024","unstructured":"Qin W, Li J, Gao N, Kong X, Guo L, Chen Y, et al. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer. Mol Cancer. 2024;23:99.","journal-title":"Mol Cancer"},{"issue":"12","key":"1883_CR10","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.3390\/molecules28124768","volume":"28","author":"AN Neagu","year":"2023","unstructured":"Neagu AN, Whitham D, Bruno P, Morrissiey H, Darie CA, Darie CC. Omics-Based Investigations of Breast Cancer. Molecules. 2023;28(12):4768.","journal-title":"Molecules"},{"key":"1883_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/1878-0261.12850","volume":"15","author":"T Terkelsen","year":"2021","unstructured":"Terkelsen T, Pernemalm M, Gromov P, Borresen-Dale AL, Krogh A, Haakensen VD, et al. High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers. Mol Oncol. 2021;15:429\u201361.","journal-title":"Mol Oncol"},{"key":"1883_CR12","doi-asserted-by":"publisher","first-page":"e45547","DOI":"10.2196\/45547","volume":"9","author":"K Bae","year":"2023","unstructured":"Bae K, Jeon YS, Hwangbo Y, Yoo CW, Han N, Feng M. Data-Efficient Computational Pathology Platform for Faster and Cheaper Breast Cancer Subtype Identifications: Development of a Deep Learning Model. JMIR Cancer. 2023;9:e45547.","journal-title":"JMIR Cancer"},{"key":"1883_CR13","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1038\/s41467-022-34275-9","volume":"13","author":"G Shamai","year":"2022","unstructured":"Shamai G, Livne A, Polonia A, Sabo E, Cretu A, Bar-Sela G, et al. Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer. Nat Commun. 2022;13:6753.","journal-title":"Nat Commun"},{"key":"1883_CR14","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 2017;77:e104\u20137.","journal-title":"Cancer Res"},{"key":"1883_CR15","doi-asserted-by":"publisher","first-page":"e197700","DOI":"10.1001\/jamanetworkopen.2019.7700","volume":"2","author":"G Shamai","year":"2019","unstructured":"Shamai G, Binenbaum Y, Slossberg R, Duek I, Gil Z, Kimmel R. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer. JAMA Netw Open. 2019;2:e197700.","journal-title":"JAMA Netw Open"},{"key":"1883_CR16","doi-asserted-by":"publisher","first-page":"1145300","DOI":"10.3389\/fimmu.2023.1145300","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu X, Xie L, Ge J, Li H, Zhong S, Liu X. Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma. Front Immunol. 2023;14:1145300.","journal-title":"Front Immunol"},{"issue":"6","key":"1883_CR17","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.3390\/ijms23063042","volume":"23","author":"R Ahmed","year":"2022","unstructured":"Ahmed R, Zaman T, Chowdhury F, Mraiche F, Tariq M, Ahmad IS, et al. Single-cell rna sequencing with spatial transcriptomics of cancer tissues. Int J Mol Sci. 2022;23(6):3042.","journal-title":"Int J Mol Sci"},{"key":"1883_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-022-01236-0","volume":"15","author":"SQ Liu","year":"2022","unstructured":"Liu SQ, Gao ZJ, Wu J, Zheng HM, Li B, Sun S, et al. Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer. J Hematol Oncol. 2022;15:19.","journal-title":"J Hematol Oncol"},{"key":"1883_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5114\/pjp.2024.146147","volume":"75","author":"W Chu","year":"2024","unstructured":"Chu W, Chu C, Ding Z, Guan W, Li S, Jiang J, et al. Predicting TNFRSF4 expression and prognosis in head and neck squamous cell carcinoma tissue: a pathological image analysis approach. Pol J Pathol. 2024;75:287\u2013304.","journal-title":"Pol J Pathol"},{"key":"1883_CR20","doi-asserted-by":"publisher","first-page":"1410603","DOI":"10.3389\/fimmu.2024.1410603","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang C, Yang G, Feng G, Deng C, Zhang Q, Chen S. Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns. Front Immunol. 2024;15:1410603.","journal-title":"Front Immunol"},{"key":"1883_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/1568009620666200621153831","volume":"20","author":"Y Vadlamudi","year":"2020","unstructured":"Vadlamudi Y, Dey DK, Kang SC. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT. Curr Cancer Drug Targets. 2020;20:654\u201365.","journal-title":"Curr Cancer Drug Targets"},{"key":"1883_CR22","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41586-024-07894-z","volume":"634","author":"X Wang","year":"2024","unstructured":"Wang X, Zhao J, Marostica E, Yuan W, Jin J, Zhang J, et al. A pathology foundation model for cancer diagnosis and prognosis prediction. Nature. 2024;634:970\u20138.","journal-title":"Nature"},{"key":"1883_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41392-021-00729-7","volume":"6","author":"Y Xu","year":"2021","unstructured":"Xu Y, Su GH, Ma D, Xiao Y, Shao ZM, Jiang YZ. Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence. Signal Transduct Target Ther. 2021;6:312.","journal-title":"Signal Transduct Target Ther"},{"key":"1883_CR24","first-page":"93","volume":"21","author":"AH Dur Karasayar","year":"2025","unstructured":"Dur Karasayar AH, Kulac I, Kapucuoglu N. Advances in Breast Cancer Care: The Role of Artificial Intelligence and Digital Pathology in Precision Medicine. Eur J Breast Health. 2025;21:93\u2013100.","journal-title":"Eur J Breast Health"},{"key":"1883_CR25","doi-asserted-by":"publisher","first-page":"105276","DOI":"10.1016\/j.ebiom.2024.105276","volume":"107","author":"D Choudhury","year":"2024","unstructured":"Choudhury D, Dolezal JM, Dyer E, Kochanny S, Ramesh S, Howard FM, et al. Developing a low-cost, open-source, locally manufactured workstation and computational pipeline for automated histopathology evaluation using deep learning. EBioMedicine. 2024;107:105276.","journal-title":"EBioMedicine"},{"key":"1883_CR26","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41419-024-07221-4","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Gao Z, Yang Y, Li Z, Wu B, Fan C, et al. SNF2L maintains glutathione homeostasis by initiating SLC7A11 transcription through chromatin remodeling. Cell Death Dis. 2024;15:820.","journal-title":"Cell Death Dis"},{"key":"1883_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41420-021-00666-y","volume":"7","author":"M Cui","year":"2021","unstructured":"Cui M, Liu D, Xiong W, Wang Y, Mi J. ERRFI1 induces apoptosis of hepatocellular carcinoma cells in response to tryptophan deficiency. Cell Death Discov. 2021;7:274.","journal-title":"Cell Death Discov"},{"key":"1883_CR28","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35:1304\u201326.","journal-title":"Cell Metab"},{"key":"1883_CR29","doi-asserted-by":"publisher","first-page":"e931102","DOI":"10.12659\/MSM.931102","volume":"27","author":"X Liu","year":"2021","unstructured":"Liu X, Wang Q, Song S, Feng M, Wang X, Li L, et al. Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients. Med Sci Monit. 2021;27:e931102.","journal-title":"Med Sci Monit"},{"issue":"18","key":"1883_CR30","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.3390\/ijms21186835","volume":"21","author":"J Weisse","year":"2020","unstructured":"Weisse J, Rosemann J, Krauspe V, Kappler M, Eckert AW, Haemmerle M, et al. RNA-Binding proteins as regulators of migration, invasion and metastasis in oral squamous cell carcinoma. Int J Mol Sci. 2020;21(18):6835.","journal-title":"Int J Mol Sci"},{"key":"1883_CR31","doi-asserted-by":"publisher","first-page":"1451130","DOI":"10.3389\/fonc.2025.1451130","volume":"15","author":"L Wang","year":"2025","unstructured":"Wang L, Zhang M, Zhao K, Yuan X, Zhao H, Liu Y, et al. The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes. Front Oncol. 2025;15:1451130.","journal-title":"Front Oncol"},{"key":"1883_CR32","doi-asserted-by":"publisher","first-page":"27386","DOI":"10.1074\/jbc.M114.589432","volume":"289","author":"H Ishii","year":"2014","unstructured":"Ishii H, Saitoh M, Sakamoto K, Kondo T, Katoh R, Tanaka S, et al. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. J Biol Chem. 2014;289:27386\u201399.","journal-title":"J Biol Chem"},{"key":"1883_CR33","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41598-025-85498-x","volume":"15","author":"X Ling","year":"2025","unstructured":"Ling X, Bazyar S, Ferris M, Molitoris J, Allor E, Thomas H, et al. Identification of CT based radiomic biomarkers for progression free survival in head and neck squamous cell carcinoma. Sci Rep. 2025;15:1279.","journal-title":"Sci Rep"},{"key":"1883_CR34","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1016\/j.crad.2024.01.029","volume":"79","author":"S Singh","year":"2024","unstructured":"Singh S, Dehghani Firouzabadi F, Chaurasia A, Homayounieh F, Ball MW, Huda F, et al. CT-derived radiomics predict the growth rate of renal tumours in von Hippel-Lindau syndrome. Clin Radiol. 2024;79:e675\u201381.","journal-title":"Clin Radiol"},{"issue":"2","key":"1883_CR35","doi-asserted-by":"publisher","first-page":"EMBR201846078","DOI":"10.15252\/embr.201846078","volume":"20","author":"Y Gokmen-Polar","year":"2019","unstructured":"Gokmen-Polar Y, Neelamraju Y, Goswami CP, Gu Y, Gu X, Nallamothu G, et al. Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways. EMBO Rep. 2019;20(2):EMBR201846078.","journal-title":"EMBO Rep"},{"key":"1883_CR36","doi-asserted-by":"publisher","first-page":"zcaa021","DOI":"10.1093\/narcan\/zcaa021","volume":"2","author":"N Ahuja","year":"2020","unstructured":"Ahuja N, Ashok C, Natua S, Pant D, Cherian A, Pandkar MR, et al. Hypoxia-induced TGF-beta-RBFOX2-ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer. NAR Cancer. 2020;2:zcaa021.","journal-title":"NAR Cancer"},{"key":"1883_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","volume":"442","author":"S Wen","year":"2019","unstructured":"Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin beta3-p38 MAPK signalling. Cancer Lett. 2019;442:320\u201332.","journal-title":"Cancer Lett"},{"issue":"4","key":"1883_CR38","doi-asserted-by":"publisher","first-page":"e130751","DOI":"10.1172\/jci.insight.130751","volume":"5","author":"HM Brechbuhl","year":"2020","unstructured":"Brechbuhl HM, Barrett AS, Kopin E, Hagen JC, Han AL, Gillen AE, et al. Fibroblast subtypes define a metastatic matrisome in breast cancer. JCI Insight. 2020;5(4):e130751.","journal-title":"JCI Insight"},{"issue":"5","key":"1883_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/cancers11050726","volume":"11","author":"S Suriyamurthy","year":"2019","unstructured":"Suriyamurthy S, Baker D, Ten Dijke P, Iyengar PV. Epigenetic Reprogramming of TGF-beta signaling in breast cancer. Cancers (Basel). 2019;11(5):726.","journal-title":"Cancers Basel"},{"key":"1883_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2019.02.044","volume":"452","author":"X Tang","year":"2019","unstructured":"Tang X, Tu G, Yang G, Wang X, Kang L, Yang L, et al. Autocrine TGF-beta1\/miR-200s\/miR-221\/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation. Cancer Lett. 2019;452:79\u201389.","journal-title":"Cancer Lett"},{"issue":"1","key":"1883_CR41","doi-asserted-by":"publisher","first-page":"BSR20190756","DOI":"10.1042\/BSR20190756","volume":"40","author":"CM Weng","year":"2020","unstructured":"Weng CM, Li Q, Chen KJ, Xu CX, Deng MS, Li T, et al. Bleomycin induces epithelial-to-mesenchymal transition via bFGF\/PI3K\/ESRP1 signaling in pulmonary fibrosis. Biosci Rep. 2020;40(1):BSR20190756.","journal-title":"Biosci Rep"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01883-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:58:50Z","timestamp":1787839130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01883-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1883"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01883-y","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, The Ethics Committee of Longyan First Affiliated Hospital of Fujian Medical University deemed that this research is based on open-source data, so the need for ethics approval was waived.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}